Skip to content

US · RADX

Radiopharm Theranostics Limited

Programmatic access: InvestorsCraft Valuation API · catalog

Sector
Healthcare · Biotechnology
Headquarters
Carlton, VIC 3053

Price · as of 2026-09-03

$2.15

Market cap 3.61M

Price history

Weekly OHLC price history for RADX, USD per share
WeekOpenHighLowCloseVolume
Dec 2, 2024 – Dec 6, 2024$5.60$50.82$5.60$18.900
Dec 9, 2024 – Dec 13, 2024$10.70$14.00$5.52$5.630
Dec 16, 2024 – Dec 20, 2024$5.00$5.76$4.20$4.390
Dec 23, 2024 – Dec 27, 2024$4.27$5.17$3.55$4.670
Dec 30, 2024 – Jan 3, 2025$5.04$5.61$4.11$4.620
Jan 6, 2025 – Jan 10, 2025$4.64$5.61$3.70$5.350
Jan 13, 2025 – Jan 17, 2025$5.50$7.05$4.55$5.340
Jan 20, 2025 – Jan 24, 2025$5.50$5.79$4.58$4.830
Jan 27, 2025 – Jan 31, 2025$4.92$5.59$4.26$4.640
Feb 3, 2025 – Feb 7, 2025$4.66$5.07$3.96$4.900
Feb 10, 2025 – Feb 14, 2025$4.96$5.00$4.63$4.770
Feb 17, 2025 – Feb 21, 2025$4.62$4.97$4.50$4.680
Feb 24, 2025 – Feb 28, 2025$4.64$6.49$4.45$5.000
Mar 3, 2025 – Mar 7, 2025$5.18$11.00$5.00$6.410
Mar 10, 2025 – Mar 14, 2025$6.50$6.90$5.07$5.800
Mar 17, 2025 – Mar 21, 2025$5.90$6.84$5.50$5.700
Mar 24, 2025 – Mar 28, 2025$6.00$6.15$5.32$5.400
Mar 31, 2025 – Apr 4, 2025$5.56$5.57$4.27$4.340
Apr 7, 2025 – Apr 11, 2025$3.81$5.20$3.50$4.470
Apr 14, 2025 – Apr 17, 2025$4.40$5.28$3.83$4.300
Apr 21, 2025 – Apr 25, 2025$4.13$4.44$3.69$4.070
Apr 28, 2025 – May 2, 2025$3.86$4.50$3.80$4.150
May 5, 2025 – May 9, 2025$4.06$4.59$3.77$4.180
May 12, 2025 – May 16, 2025$4.20$4.40$3.80$4.150
May 19, 2025 – May 23, 2025$4.40$6.15$4.01$4.810
May 26, 2025 – May 30, 2025$5.16$5.20$4.53$4.650
Jun 2, 2025 – Jun 6, 2025$5.16$5.50$4.77$4.910
Jun 9, 2025 – Jun 13, 2025$4.85$5.69$4.68$5.050
Jun 16, 2025 – Jun 20, 2025$5.25$5.44$4.05$4.510
Jun 23, 2025 – Jun 27, 2025$4.68$5.04$4.10$4.720
Jun 30, 2025 – Jul 3, 2025$4.80$4.95$3.80$3.980
Jul 7, 2025 – Jul 11, 2025$4.06$4.80$3.81$4.140
Jul 14, 2025 – Jul 18, 2025$4.30$4.84$4.07$4.430
Jul 21, 2025 – Jul 25, 2025$4.55$5.00$4.28$4.710
Jul 28, 2025 – Aug 1, 2025$4.83$5.90$4.40$5.350
Aug 4, 2025 – Aug 8, 2025$5.65$5.75$4.59$4.680
Aug 11, 2025 – Aug 15, 2025$4.63$5.73$4.55$4.890
Aug 18, 2025 – Aug 22, 2025$4.95$7.28$4.80$5.670
Aug 25, 2025 – Aug 29, 2025$5.86$5.92$5.21$5.490
Sep 1, 2025 – Sep 5, 2025$5.50$6.00$4.91$5.750
Sep 8, 2025 – Sep 12, 2025$6.00$6.99$5.21$6.500
Sep 15, 2025 – Sep 19, 2025$6.37$7.74$6.37$6.490
Sep 22, 2025 – Sep 26, 2025$6.49$7.06$4.97$5.750
Sep 29, 2025 – Oct 3, 2025$5.83$6.30$5.43$6.200
Oct 6, 2025 – Oct 10, 2025$6.85$7.69$6.02$7.030
Oct 13, 2025 – Oct 17, 2025$7.08$7.71$6.80$7.110
Oct 20, 2025 – Oct 24, 2025$5.89$7.00$5.21$5.330
Oct 27, 2025 – Oct 31, 2025$5.26$5.50$4.79$5.260
Nov 3, 2025 – Nov 7, 2025$5.24$5.24$4.53$5.000
Nov 10, 2025 – Nov 14, 2025$4.86$4.96$4.31$4.400
Nov 17, 2025 – Nov 21, 2025$4.63$5.37$4.15$4.550
Nov 24, 2025 – Nov 28, 2025$4.67$4.97$4.45$4.560
Dec 1, 2025 – Dec 5, 2025$4.69$4.92$4.05$4.750
Dec 8, 2025 – Dec 12, 2025$4.84$4.95$3.62$4.260
Dec 15, 2025 – Dec 19, 2025$13.91$16.25$5.12$5.190
Dec 22, 2025 – Dec 26, 2025$5.35$5.81$4.77$5.500
Dec 29, 2025 – Jan 2, 2026$5.50$5.50$5.03$5.160
Jan 5, 2026 – Jan 9, 2026$5.20$5.28$4.67$5.150
Jan 12, 2026 – Jan 16, 2026$5.16$5.30$4.94$5.140
Jan 19, 2026 – Jan 23, 2026$4.99$5.19$4.85$4.930
Jan 26, 2026 – Jan 30, 2026$4.89$5.09$4.82$5.050
Feb 2, 2026 – Feb 6, 2026$4.83$5.46$4.69$4.970
Feb 9, 2026 – Feb 13, 2026$4.99$5.20$4.70$4.900
Feb 16, 2026 – Feb 20, 2026$4.90$5.19$4.76$4.980
Feb 23, 2026 – Feb 27, 2026$5.05$5.55$4.80$4.990
Mar 2, 2026 – Mar 6, 2026$4.93$5.12$4.64$4.990
Mar 9, 2026 – Mar 13, 2026$4.89$5.10$4.74$4.750
Mar 16, 2026 – Mar 20, 2026$4.85$4.98$4.44$4.800
Mar 23, 2026 – Mar 27, 2026$4.69$4.77$3.90$4.250
Mar 30, 2026 – Apr 2, 2026$4.20$4.45$4.11$4.400
Apr 6, 2026 – Apr 10, 2026$4.41$4.67$4.25$4.660
Apr 13, 2026 – Apr 17, 2026$4.43$4.65$4.41$4.580
Apr 20, 2026 – Apr 24, 2026$4.61$4.82$4.45$4.510
Apr 27, 2026 – May 1, 2026$4.50$4.75$4.26$4.410
May 4, 2026 – May 8, 2026$4.50$4.73$3.96$4.000
May 11, 2026 – May 15, 2026$3.97$4.79$3.96$4.710
May 18, 2026 – May 22, 2026$4.50$4.80$4.42$4.630
May 25, 2026 – May 29, 2026$4.70$4.70$4.42$4.580
Jun 1, 2026 – Jun 5, 2026$4.50$4.79$4.21$4.320
Jun 8, 2026 – Jun 12, 2026$4.41$4.45$4.04$4.270
Jun 15, 2026 – Jun 18, 2026$4.41$4.54$4.10$4.450
Jun 22, 2026 – Jun 26, 2026$4.36$4.48$3.95$4.020
Jun 29, 2026 – Jul 2, 2026$4.10$4.40$4.00$4.370
Jul 6, 2026 – Jul 10, 2026$4.35$4.49$4.11$4.370
Jul 13, 2026 – Jul 17, 2026$4.26$4.43$4.11$4.430
Jul 20, 2026 – Jul 24, 2026$4.39$4.42$2.73$3.550
Jul 27, 2026 – Jul 31, 2026$3.26$3.88$2.85$3.150
Aug 3, 2026 – Aug 7, 2026$3.04$3.28$2.62$2.800
Aug 10, 2026 – Aug 14, 2026$2.77$2.94$2.45$2.560
Aug 17, 2026 – Aug 21, 2026$2.56$2.79$2.23$2.440
Aug 24, 2026 – Aug 28, 2026$2.43$2.72$2.04$2.410
Aug 31, 2026 – Sep 3, 2026$2.37$2.44$2.05$2.150

Valuation

MetricValueUpside
IC Value$2.30+7%
P/E
P/B1.26
P/S15.53
EV/EBITDA-0.72
PEG
P/TBV-31.65

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

Annual price and model valuations for RADX, USD per share
YearPriceAIICGraham-DoddGraham Formula
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025$5.75$50.02

Historic valuation ratios

Pick a category, then toggle metrics to compare.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Radiopharm Theranostics Limited

        Radiopharm Theranostics Limited, an Australian company established in Carlton in 2021, specializes in the research and development of cutting-edge radiopharmaceutical treatments. Their mission is to address critical gaps in healthcare by creating products for both diagnostic imaging and therapeutic intervention across a spectrum of challenging medical conditions. The company's diverse pipeline features: RAD 204, designed to target PD-L1 for non-small cell lung cancer; RAD 202, aimed at HER2 for breast cancer and other solid tumor types; and two avß6 integrin-targeting agents, RAD 301 (a diagnostic tool for pancreatic ductal adenocarcinoma) and RAD 302 (a therapeutic agent for various cancers). Other significant developments include RAD 101 and RAD 102 for brain metastases, RAD 402 for advanced prostate cancer, and RV01 for multiple solid tumors. To accelerate the clinical progression of its radiopharmaceutical assets, Radiopharm Theranostics maintains a strategic partnership with Lantheus Holdings, Inc.

        CEO
        Riccardo Canevari
        Employees
        14
        Beta
        0.80

        Peer comparison

        Same-industry comparables, ranked by market cap.

        Scroll horizontally for additional metrics. Ticker column stays fixed.

        Peer comparison for RADX: basic info, valuation models, ratios, profitability, leverage, growth, cash flow, dividends, enterprise value, and Altman Z-score.
        Basic InfoIC ValuationCore ValuationProfitabilityLeverage & LiquidityGrowthCash FlowDividendsEnterprise ValueRisk
        TickerCompany NamePriceMarket CapValueUpsideP/EP/BP/SEV/EBITDAPEGP/TBVGross MarginOperating MarginNet MarginROEROICROADebt/EquityInterest CoverageCurrent RatioQuick RatioNet Debt/EBITDAEPS GrowthSales GrowthFCF GrowthFCF YieldOp Cash Flow RatioCash ROICDividend YieldDividend PayoutShareholder YieldEV/EBITEV/FCFEV/SalesAltman Z-Score
        RADXRadiopharm Theranostics L…$2.803.61M$50.02+1,686%1.2615.53-0.72-31.651.08%-1050.63%-1055.27%0.00%-302.69%0.00%0.00-584.592.672.650.76-85.33%1114.27%59.50%-64.96%-2.45-290.58%0.00%18.69%-0.72-0.747.51-2.65
        ADXNAddex Therapeutics Ltd$5.226.43M$510.24+9,683%-0.791.09173.32-0.531.09100.00%-9390.76%-22448.44%-90.49%-59.05%-76.68%0.01-1162.581.401.380.24-181.90%-92.58%-61.38%-39.96%-1.73-43.55%0.00%0.00%0.00%-1.28-1.73119.75-78.69
        CDIOCardio Diagnostics Holdin…$1.753.62M$14.43+724%-0.750.70330.79-0.080.80100.00%-43737.46%-43832.49%-78.62%-246.61%-70.70%0.10-438.089.798.460.73-60.11%-57.51%9.58%-120.60%-9.47-224.94%0.00%0.00%0.00%-0.08-0.0832.98-3.49
        CYCNCyclerion Therapeutics, I…$3.5516.62M$39.93+1,025%-1.330.512.25-0.410.51100.00%-239.78%-170.11%-39.34%-86.77%-36.07%0.005.154.710.92-9.92%3.70%-23.52%-70.87%-3.68-57.82%0.00%0.00%2.95%-0.29-0.430.69-35.87
        KTTAPasithea Therapeutics Cor…$0.453.35M0.000.102.450.110.00%0.00%0.00%-58363.21%-526.68%-53542.34%0.0011.3511.092.73-77.07%109150.95%-263840.10%-3058.22-384116.60%0.00%0.00%836.65%2.370.00-1.06
        QNRXQuoin Pharmaceuticals, Lt…$4.378.78M-0.760.92242.35-0.030.00%0.00%0.00%-142.71%0.86%-88.26%0.003.61688.33243.12-84.10%72.34%-112.13%-2.440.71%0.00%0.00%31585.93%233.63281.07-5.66
        TCRTAlaunos Therapeutics, Inc…$2.024.93M$91.89+4,449%-1.542.991285.92-1.212.99-27160.00%-84500.00%-83520.00%-198.10%-485.63%-145.99%0.002.451.710.33-24.66%-50.00%-40.31%-46.15%-3.53-341.03%0.00%0.00%4.57%-1.19-1.701008.92-435.92

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($2.30 ÷ $2.15) − 1 = +6.98% (IC, example).